The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11001639 B1

PDF
Full Text
Expired
Date of Patent:
May. 11, 2021

Filed:

Jan. 23, 2019
Applicant:

Xuanwu Hospital Capital Medical University, Beijing, CN;

Inventors:

Zhiguo Chen, Beijing, CN;

Yu Zhao, Beijing, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/02 (2006.01); A61K 39/00 (2006.01); C07K 14/725 (2006.01); A61K 35/17 (2015.01); C07K 14/705 (2006.01); A61K 47/65 (2017.01); A61P 35/04 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 35/17 (2013.01); A61K 39/0011 (2013.01); A61K 47/65 (2017.08); A61P 35/02 (2018.01); A61P 35/04 (2018.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 16/2803 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); C07K 2317/622 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01);
Abstract

Chimeric antigen receptors for efficient and selective in vitro proliferation and uses thereof. Specifically, the present invention provides a CAR-encoding molecule with specific selectivity in vitro. By introducing a humanized selective domain into the molecule, the CAR-positive cells after being infected can be efficiently sorted via a secondary sorting step. Upon exposure to the selective domain-specific antibody, the CAR-transduced immune cells can be selectively expanded; therefore, the ratio of the CAR-positive target cells in the final product is significantly increased, improving the efficiency of preparing CAR gene-modified immune cell products. The present invention provides a more reliable technical support for further promotion and application of such products in clinical practice.


Find Patent Forward Citations

Chen, Zhiguo. (2021). Chimeric antigen receptor for efficient selective proliferation in vitro and uses thereof (U.S. Patent No. 11001639). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11001639

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…